The majority of cancer patients develop decreased oral intake before death. Dehydration can cause or aggravate symptoms such as fatigue, myoclonus, sedation, hallucinations and delirium. The controversy regarding the effects of hydration at the end of life has resulted in heated debate in American media and in medical literature. In the United States, patients with advanced cancer who have dehydration or decreased oral intake nearly always receive parenteral hydration in acute care facilities but almost never in hospices. Unfortunately, the decision of giving or not giving fluid in advanced cancer patients at the end of life is complicated by nearly complete absence of randomized controlled trials focusing on the potential advantages and disadvantages of parenteral hydration. The only randomized, double blind controlled study conducted by our group suggested that parenteral hydration decreased symptoms associated with dehydration in terminally ill cancer patients as compared with placebo. Our long -term goal of this study is to understand the effect of parenteral hydration on the quality and quantity of life in terminally ill cancer patients and their primary caregivers We propose this randomized, controlled clinical trial to determine whether parenteral hydration (1,000 mL normal saline/day) is superior to placebo (100 ml normal saline) in improving symptoms associated with dehydration such as fatigue, myoclonus, sedation, hallucinations and delirium in patients with advanced cancer receiving hospice care, whether parenteral hydration is superior to placebo in delaying the onset or decreased severity of delirium, whether parenteral hydration is superior to placebo in prolonging survival and to describe the meaning of dehydration and re-hydration at the end of life to family primary caregivers. In order to achieve these goals, a battery of symptom assessments will be mesured at study resgistration, during treatment and at the end of the treatment. We hypothesize that patients receiving parenteral hydration will demonstrate reduced symptom burden, delayed onset and reduced severity of delirium, and prolonged survival. In this study, we will test if giving fluid through the vein will improve the symptoms, delay confusion and prolong life in patients who are no longer to drink at the end of life. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA122292-03
Application #
7479116
Study Section
Behavioral Medicine, Interventions and Outcomes Study Section (BMIO)
Program Officer
O'Mara, Ann M
Project Start
2006-09-15
Project End
2010-07-31
Budget Start
2008-08-01
Budget End
2009-07-31
Support Year
3
Fiscal Year
2008
Total Cost
$504,972
Indirect Cost
Name
University of Texas MD Anderson Cancer Center
Department
Physical Medicine & Rehab
Type
Other Domestic Higher Education
DUNS #
800772139
City
Houston
State
TX
Country
United States
Zip Code
77030
Kwon, Jung Hye; Kim, Min Ji; Bruera, Sebastian et al. (2017) Off-Label Medication Use in the Inpatient Palliative Care Unit. J Pain Symptom Manage 54:46-54
Ng, Amy H; Gupta, Ekta; Fontillas, Rhodora C et al. (2017) Patient-Reported Usefulness of Acute Cancer Rehabilitation. PM R 9:1135-1143
Dalal, Shalini; Bruera, Eduardo (2017) End-of-Life Care Matters: Palliative Cancer Care Results in Better Care and Lower Costs. Oncologist 22:361-368
Dalal, Shalini; Bruera, Sebastian; Hui, David et al. (2016) Use of Palliative Care Services in a Tertiary Cancer Center. Oncologist 21:110-8
Kim, Yu Jung; Dev, Rony; Reddy, Akhila et al. (2016) Association Between Tobacco Use, Symptom Expression, and Alcohol and Illicit Drug Use in Advanced Cancer Patients. J Pain Symptom Manage 51:762-8
Delgado-Guay, Marvin Omar; Rodriguez-Nunez, Alfredo; Shin, Seong Hoon et al. (2016) Characteristics and outcomes of patients with advanced cancer evaluated by a palliative care team at an emergency center. A retrospective study. Support Care Cancer 24:2287-2295
Tayjasanant, Supakarn; Bruera, Eduardo; Hui, David (2016) How far along the disease trajectory? An examination of the time-related patient characteristics in the palliative oncology literature. Support Care Cancer 24:3997-4004
Hui, David; Park, Minjeong; Shamieh, Omar et al. (2016) Personalized symptom goals and response in patients with advanced cancer. Cancer 122:1774-81
Hui, David; Kilgore, Kelly; Park, Minjeong et al. (2016) Impact of Prophylactic Fentanyl Pectin Nasal Spray on Exercise-Induced Episodic Dyspnea in Cancer Patients: A Double-Blind, Randomized Controlled Trial. J Pain Symptom Manage 52:459-468.e1
Hui, David; Kilgore, Kelly; Frisbee-Hume, Susan et al. (2016) Dexamethasone for Dyspnea in Cancer Patients: A Pilot Double-Blind, Randomized, Controlled Trial. J Pain Symptom Manage 52:8-16.e1

Showing the most recent 10 out of 130 publications